qPCR Reagents Market - Forecast(2024 - 2030)

Report Code: HCR 0476 Report Format: PDF + Excel

qPCR Reagents Market Overview

qPCR Reagents Market size is estimated to reach $2,932 million by 2026, growing at a CAGR of 7.7% during the forecast period 2021-2026. Quantitative PCR (q PCR) Reagents utilize the linearity of DNA amplification to conclude absolute or relative quantities of a recognized sequence in a sample. qPCR (Quantitative Polymerase Chain Reaction) indicates real-time polymerase chain reaction or quantitative PCR, which permits concurrent amplification and detection of DNA in real-time. Quantitative polymerase chain reaction (qPCR) is a technique by which the quantity of the PCR product may be established, in real-time, and is very beneficial for examining gene expression. Quantitative PCR, irrespective of including a reverse transcription step or not, is conventionally utilized in molecular biology laboratories.

The increasing population of senior citizens is set to drive the qPCR Reagents Market owing to the boost in demand for genetic tests which may involve real-time polymerase chain reactions. The surge in the count of genome projects needing gene sequencing and genetic tests to comprehend the human gene sequence is set to propel the growth of the qPCR Reagents Market during the forecast period 2021-2026. This represents the qPCR Reagents Industry Outlook. 

Report Coverage

The report: qPCR Reagents Market Forecast (2021-2026)”, by Industry ARC, covers an in-depth analysis of the following segments of the qPCR Reagents Market.

By Detection Method: Dye-Based qPCR Reagents, Probes & Primer-Based qPCR Reagents.
By Packaging Type: qPCR Core Kits, qPCR Mastermixes.
By Application: Diagnostic, Research, Forensic.
By End User: Hospitals and Diagnostic Centers, Research Laboratories and Academic Institutes, Pharmaceutical and Biotechnology Companies, Clinical Research Organizations (CROs), Forensic Laboratories.
By Geography: North America (the U.S, Canada, and Mexico), Europe (UK, Germany, France, Italy, Spain, Russia and Rest of Europe), Asia-Pacific (China, India, Japan, South Korea, Australia & New Zealand, and Rest of Asia-Pacific), South America (Brazil, Argentina, Rest of South America) and Rest Of The World (Middle East, Africa).

Key Takeaways

  • Geographically, North America qPCR Reagents Market accounted for the highest revenue share in 2020 and it is poised to dominate the market over the period 2021-2026 owing to the increasing predominance of cancer and infectious ailments involving real-time polymerase chain reaction in the North American region resulting in heightening demand for qPCR reagents.
  • qPCR Reagents Market growth is being driven by the growing occurrences of genetic ailments requiring real-time polymerase chain reaction and resulting in a boost in demand for diagnostic tests enabling people to take precautionary actions. However, the soaring cost of qPCR machinery and dearth of great technical competence to handle qPCR machinery is one of the major factors hampering the growth of the qPCR Reagents Market. 
  • qPCR Reagents Market Detailed Analysis on the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the qPCR Reagents Market report.

qPCR Reagents Market Share, By Detection Method, 2020(%)

qPCR Reagents Market Share

For More Details on This Report - Request for Sample

qPCR Reagents Market Segment Analysis – By Detection Method:

The qPCR Reagents Market based on detection method can be further segmented into Dye-Based qPCR Reagents and Probes & Primer-Based qPCR Reagents. The Dye-Based qPCR Reagents Segment held the largest market share in 2020. This growth is owing to the increased application of fluorescent DNA-binding dyes in the supervision of DNA Synthesis. qPCR involves a real-time polymerase chain reaction. The characteristic of increasing fluorescence of dyes with the existence of double-stranded DNA is further propelling the growth of this segment.

Furthermore, the Dye-Based qPCR Reagents segment is estimated to grow with the fastest CAGR of 8.2% during the forecast period 2021-2026 owing to the extensive application of dye-based diagnostic qualitative PCR for the accelerated diagnostic discovery of nucleic acids indicative of infectious ailments, cancer, and genetic abnormalities which may involve real-time polymerase chain reaction.

qPCR Reagents Market Segment Analysis – By Packaging Type:

The qPCR Reagents Market based on packaging type can be further segmented into qPCR Core Kits and qPCR Mastermixes. The qPCR Core Kits Segment held the largest market share in 2020. This growth is owing to the increased affordability of core kits which are available at lesser prices in comparison with qPCR Mastermixes. qPCR involves a real-time polymerase chain reaction. The increased flexibility offered to end-users is further propelling the growth of this segment owing to its suitability for building independent response protocols by researchers.

Furthermore, the qPCR Mastermixes segment is estimated to grow with the fastest CAGR of 8.4% during the forecast period 2021-2026 owing to the surging availability of optimized MasterMixes like Canvax™ qMAXSen™ products which are inclusive of all the constituents for a real-time polymerase chain reaction, except sample DNA and Primers and provide a phenomenal Sensitivity and Performance for the two most utilized qPCR techniques termed intercalating Green Dyes based or Probe-based assays.

qPCR Reagents Market Segment Analysis – By Geography:

The qPCR Reagents Market based on geography can be further segmented into North America, Europe, Asia-Pacific, South America, and the Rest of the World. North America (qPCR Reagents Market) held the largest share with 33% of the overall market in 2020. The growth of this region is owing to the well-established healthcare system and the soaring concentration of key players like Takara Bio in the region. The increased impetus for research and development in conjunction with increased demand for qPCR diagnostic tests involving real-time polymerase chain reaction is further fueling the growth of the qPCR Reagents Market in the North-American region.

Furthermore, the Asia-Pacific region is estimated to be the region with the fastest CAGR rate over the forecast period 2021-2026. This growth is owing to factors like the increasing population of the elderly and the altering patterns of healthcare spending. The increasing birth rate, the heightening count of clinical laboratories, and the soaring acceptance of qPCR Reagents involving real-time polymerase chain reaction in Forensics are fuelling the progress of the qPCR Reagents Market in the Asia-Pacific region.

qPCR Reagents Market Drivers

Global Prevalence Of Incessant Ailments Is Projected To Drive The Growth Of qPCR Reagents Market:

As per World Health Organization (WHO), nearly 70% of demises from cancer, happen in low- and middle-income countries. Furthermore, WHO figures indicate that the total yearly cost of cancer in 2010 was approximated at the U.S. $1.16 trillion. PCR (Polymerase Chain Reaction), qPCR (Quantitative Polymerase Chain Reaction), and RT-qPCR (Reverse transcription – Quantitative Polymerase Chain Reaction) are molecular procedures that permit for the discovery and assessment of genes and gene expression in an assortment of sample sources. These procedures permit the accelerated, sensitive, and precise discovery of possible cancer biomarkers. The increasing count of cancer cases is resulting in the greater application of real-time polymerase chain reaction which is fuelling the growth of the qPCR Reagents Market during the forecast period 2021-2026.

Technological Innovations Are Expected To Boost The Demand Of qPCR Reagents:

Technological innovations are driving the growth of the qPCR Reagents market. The AriaMx Real-time PCR (Real-Time Polymerase Chain Reaction) System developed by Agilent is a completely combined quantitative PCR amplification, discovery, and data analysis system. The AriaMx amplifies the output with its rare modular and malleable design, instinctive touch-screen interface, progressive, effortless reporting, and 120+ attributes supervised by way of the built-in onboard diagnostics to assist in locating assay or instrument issues as they come up. The real-time PCR (Real-Time Polymerase Chain Reaction) specialty kits and reagents developed by Agilent are quick, effective, and deliver great specificity These kinds of technological innovations are driving the growth of the qPCR Reagents Market during the forecast period 2021-2026.

qPCR Reagents Market Challenges

Limitations Of Real-Time PCR Are Challenging The qPCR Reagents Market:

Real-Time Polymerase Chain Reaction has limitations like PCR product rises exponentially and it is not possible to supervise the amplicon size. There is a boost in variation with cycle number. An utmost of four concurrent reactions can be considered. There is an overlap of emission spectra. There is an expanded hazard of a false negative in pathogen detection, specifically for novel emerging or greatly variable pathogens. Non-specific binding is observed in SYBR green analysis. These are the disadvantages of Real-Time Polymerase Chain Reaction which are hampering the growth of the qPCR Reagents Market. Furthermore, the utilization of the qPCR procedure is unregulated worldwide, which has made end-users hesitant to utilize qPCR products in genomic analysis and ailments diagnosis which is further challenging the qPCR Reagents Market.

qPCR Reagents Market - Landscape

Product commercialization, greater funds for research, superior distribution systems, agreements, geographic expansion, collaborations, and awareness campaigns are key strategies adopted by players in the qPCR Reagents Market. Key companies of this market include:

  1. F. Hoffman-La Roche Ltd.
  2. Bio-Rad Laboratories Inc
  3. Sigma-Aldrich Corporation (Merck Kgaa)
  4. Agilent Technologies Inc.
  5. Thermo Fischer Scientific Inc
  6. Qiagen N.V.
  7. Takara Bio
  8. Affymetrix Inc.
  9. Promega Corporation
  10. Quanta Biosciences

 Acquisitions/Product Launches:

  • In October 2021, Roche introduced the AVENIO Tumor Tissue CGP Kit. The Kit supplements the present CGP portfolio provided by Roche and Foundation Medicine and permits laboratories to augment their oncology research in-house. Eventually, a forthcoming version of the kit may result in added resources for clinicians to utilize in the diagnosis and treatment of cancer.
  • In January 2021, Roche declared the CE-IVD kick-off of its automated digital pathology algorithms, uPath HER2 (4B5) image analysis, and uPath Dual ISH image analysis for breast cancer to assist in establishing the top treatment strategy for every patient. The image analysis algorithms utilize artificial intelligence to back pathologists in making quicker, more precise patient diagnoses in breast cancer. 
Related Reports:

Digital PCR (dPCR) and qPCR Market - Forecast(2021 - 2026)

Report Code: HCR 0466

Lateral Flow Assay Market - Forecast(2021 - 2026)

Report Code: HCR 0137

For more Lifesciences and Healthcare Market reports, please click here

1. qPCR Reagents Market - Overview
    1.1 Definitions and Scope
2. qPCR Reagents Market - Executive Summary
    2.1 Market Revenue, Market Size, and Key Trends
    2.2 Key trends by Detection Method
    2.3 Key trends by Packaging Type
    2.4 Key trends by Geography
3. qPCR Reagents Market - Comparative Analysis
    3.1 Company Benchmarking – Key Companies
    3.2 Financial Analysis– Key Companies
    3.3 Market Share Analysis– Key Companies
    3.4 Patent Analysis
    3.5 Pricing Analysis- Average Selling Price
4. qPCR Reagents Market - Startup Companies Scenario Premium
    4.1 Key Startup Company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Venture Capital and Funding Scenario
5. qPCR Reagents Market – Industry Market Entry Scenario Premium Premium
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing Business Index
    5.3 Case Studies of Successful Ventures
6. qPCR Reagents Market - Forces
    6.1 Market Drivers
    6.2 Market Constraints/Challenges
    6.3 Porters Five Force Model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes
7. qPCR Reagents Market – Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle
8. qPCR Reagents Market – By Detection Method (Market Size –$Million/$Billion)
    8.1 Dye-Based qPCR Reagents
    8.2 Probes and Primer-Based qPCR Reagents
9. qPCR Reagents Market – By Packaging Type (Market Size –$Million/$Billion)
    9.1 qPCR Core Kits
    9.2 qPCR Mastermixes
10. qPCR Reagents Market – By Application (Market Size –$Million/$Billion)
    10.1 Diagnostic
    10.2 Research
    10.3 Forensic
11. qPCR Reagents Market – By End User (Market Size –$Million/$Billion)
    11.1 Hospitals and Diagnostic Centers
    11.2 Research Laboratories and Academic Institutes
    11.3 Pharmaceutical and Biotechnology Companies
    11.4 Clinical Research Organizations (CROs)
    11.5 Forensic Laboratories
12. qPCR Reagents Market - By Geography (Market Size –$Million/$Billion)
    12.1 North America
        12.1.1 U.S.
        12.1.2 Canada
        12.1.3 Mexico
    12.2 Europe
        12.2.1 U.K.
        12.2.2 Germany
        12.2.3 France
        12.2.4 Italy
        12.2.5 Spain
        12.2.6 Russia
        12.2.7 Rest of Europe
    12.3 Asia-Pacific
        12.3.1 China
        12.3.2 India
        12.3.3 Japan
        12.3.4 South Korea
        12.3.5 Australia & New Zealand
        12.3.6 Rest of Asia-Pacific
    12.4 South America
        12.4.1 Brazil
        12.4.2 Argentina
        12.4.3 Rest of South America
    12.5 Rest of the World
        12.5.1 Middle East
        12.5.2 Africa
13. qPCR Reagents Market - Entropy
14. qPCR Reagents Market – Industry/Segment Competition Landscape Premium 
    14.1 Market Share Analysis
        14.1.1 Global Market Share – Key Companies
        14.1.2 Market Share by Region – Key companies
        14.1.3 Market Share by Countries – Key Companies
        14.1.4 Competition Matrix
        14.1.5 Best Practices for Companies
15. qPCR Reagents Market – Key Company List by Country Premium Premium
16. qPCR Reagents Market Company Analysis
    16.1 Company 1
    16.2 Company 2
    16.3 Company 3
    16.4 Company 4
    16.5 Company 5
    16.6 Company 6
    16.7 Company 7
    16.8 Company 8
    16.9 Company 9
    16.10 Company 10
"*Financials for private companies would be provided on a best efforts basis”.